Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Return on Sales [ROS] (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) posted Return on Sales [ROS] of 37.40% for Q2 2026, down 1.43 percentage points from 38.83% a year earlier and down 0.70 percentage points from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Vertex Pharmaceuticals was 37.95%, up 3.59 percentage points year-over-year; for FY2025, it came in at 34.77%, up 36.89 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of -11.25 percentage points (FY2020 to FY2025).
  • In prior years, Vertex Pharmaceuticals' Return on Sales [ROS] was -2.11% in FY2024 (-40.94 pp), 38.83% in FY2023 (-9.40 pp), 48.23% in FY2022 (+11.50 pp) and 36.73% in FY2021 (-9.30 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q1 2025.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of +20.16 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2025, with a gain of 171.68 percentage points; the weakest was Q2 2024, with a drop of 174.02 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 38.10% (Q1 2026), 37.80% (Q4 2025) and 38.56% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 28.21%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 37.86%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 32.97%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 20.57%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -133.21%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 28.37%
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 37.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.40%
Mar 31, 2026 38.10%
Dec 31, 2025 37.80%
Sep 30, 2025 38.56%
Jun 30, 2025 38.83%
Mar 31, 2025 22.75%
Dec 31, 2024 35.23%
Sep 30, 2024 40.27%
Jun 30, 2024 -132.85%
Mar 31, 2024 42.35%
Dec 31, 2023 39.26%
Sep 30, 2023 41.80%
Jun 30, 2023 41.17%
Mar 31, 2023 32.80%
Dec 31, 2022 44.88%
Sep 30, 2022 48.27%
Jun 30, 2022 50.37%
Mar 31, 2022 49.63%
Dec 31, 2021 42.35%
Sep 30, 2021 53.15%
API Access

Vertex Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VRTX&period=max&api_key=YOUR_API_KEY